Abstract
The aim of our study was to evaluate the prognostic significance of blood transfusion on recurrence and survival in patients undergoing curative resections for colorectal cancer. Retrospective analysis of prospectively collected data of patients after elective resections for colorectal cancer between January 2001 and December 2009 was undertaken. The main endpoint was overall survival, disease-free survival, and recurrence rate. These data were evaluated in relation to blood transfusion (group A, no blood transfusion; group B, one to two blood transfusions; group C, three and more blood transfusions). A total of 583 patients met the criteria for inclusion in the study. Of these, 132 (22.6 %) patients received blood transfusion in the perioperative period. There were 83 (14.2 %) patients who received one or two blood transfusions and 49 (8.4 %) patients who required three or more transfusions. Patients with three or more transfusions had a significantly worse 5-year overall survival, disease-free survival, and increased incidence of distant recurrences in comparison with the group without transfusion or the group with one or two transfusions. Multivariate analysis showed that the application of three or more blood transfusions is an independent risk factor for overall survival (P = 0.001; HR 2.158; 95 % CI 1.370–3.398), disease-free survival (P < 0.001; HR 2.514; 95 % CI 1.648–3.836), and the incidence of distant recurrence (P < 0.001; HR 2.902; 95 % CI 1.616–5.212). Application of three or more blood transfusions in patients operated for colorectal carcinoma is an adverse prognostic factor. Indications for blood transfusion should be carefully considered not only with regard to the risk of early complications, but also because of the possibility of compromising long-term results.
Similar content being viewed by others
References
Opelz G, Sengar DP, Mickey MR, Terasaki PI (1973) Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5:253–259
Gantt CL (1981) Red blood cells for cancer patients. Lancet 15:363
Burrows L, Tartter P (1982) Effect of blood transfusions on colonic malignancy recurrent rate. Lancet 18:662
Amato AC, Pescatori M (1998) Effect of perioperative blood transfusions on recurrence of colorectal cancer: meta-analysis stratified on risk factors. Dis Colon Rectum 41:570–885
Chiarugi M, Buccianti P, Disarli M, Galatioto C, Cavina E (2000) Effect of blood transfusions on disease-free interval after rectal cancer surgery. Hepatogastroenterology 47:1002–1005
Edna TH, Bjerkeset T (1998) Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum 41:451–459
Jagoditsch M, Pozgainer P, Klingler A, Tschmelitsch J (2006) Impact of blood transfusions on recurrence and survival after rectal cancer surgery. Dis Colon Rectum 49:1116–1130
McAlister FA, Clark HD, Wells PS, Laupacis A (1998) Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg 85:171–178
Dionigi G, Rovera F, Boni L et al (2007) The impact of perioperative blood transfusion on clinical outcomes in colorectal surgery. Surg Oncol 16(Suppl 1):S177–182
Vamvakas EC, Blajchman MA (2001) Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 97:1180–1195
Patel HB, Nasir FA, Nash GF, Scully MF, Kakkar AK (2004) Enhanced angiogenesis following allogeneic blood transfusion. Clin Lab Haematol 26:129–135
Lange MM, van Hilten JA, van de Watering LM, Cooperative clinical investigators of the Cancer Recurrence And Blood Transfusion (CRAB) study and the Transfusion Associated Complications = Transfusion Induced Complications? (TACTIC) study et al (2009) Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer. Br J Surg 96:734–740
van de Watering LM, Brand A, Houbiers JG, Klein Kranenbarg WM, Hermans J, van de Velde C, Cancer Recurrence and Blood transfusion study group (2001) Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence. Br J Surg 88:267–272
Skånberg J, Lundholm K, Haglind E (2007) Effects of blood transfusion with leucocyte depletion on length of hospital stay, respiratory assistance and survival after curative surgery for colorectal cancer. Acta Oncol 46:1123–1130
Busch OR, Hop WC, Marquet RL, Jeekel J (1994) Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship. Ann Surg 220:791–797
Amato A, Pescatori M (2006) Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 25:CD005033
Miki C, Hiro J, Ojima E, Inoue Y, Mohri Y, Kusunoki M (2006) Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol (R Coll Radiol) 18:60–66
Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ (2000) Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg 87:1553–1562
Nielsen HJ, Werther K, Mynster T, Brünner N (1999) Soluble vascular endothelial growth factor in various blood transfusion components. Transfusion 39:1078–1083
Mynster T, Nielsen HJ, Danish RANX05 Colorectal Cancer Study Group (2001) Storage time of transfused blood and disease recurrence after colorectal cancer surgery. Dis Colon Rectum 44:955–964
Dixon E, Datta I, Sutherland FR, Vauthey JN (2009) Blood loss in surgical oncology: neglected quality indicator? J Surg Oncol 99:508–512
Conflict of Interest
The authors declare that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gunka, I., Dostalik, J., Martinek, L. et al. Impact of Blood Transfusions on Survival and Recurrence in Colorectal Cancer Surgery. Indian J Surg 75, 94–101 (2013). https://doi.org/10.1007/s12262-012-0427-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-012-0427-6